Will Ewart

Director of Strategic Partnerships & Business Development @Trilodocs

London, GB

TriloDocs is redefining how clinical documents are written, starting with – but not limited to – Clinical Study Reports (CSRs). Developed by senior medical writers, it fuses deterministic, rules-based intelligence with a scoped generative layer to deliver speed, accuracy, and transparency — without the risks of LLM-only tools. Designed to think like a writer, not a chatbot, TriloDocs transforms authoring into a structured, inspection-ready workflow.At its core sit three layers of intelligence: expert-authored rules built by seasoned writers; a matrix-based deterministic parser that interprets TLFs through structure rather than probability; and a scoped narrative engine that generates language only where it adds human clarity. Every output is accurate, reproducible, and fully traceable line-by-line back to its source.TriloDocs already goes beyond CSRs. It is live today for CSRs (Module 5), using deterministic symbolic AI with built-in medical-writer intelligence to detect and analyse clinically meaningful signals while producing fully traceable TransCelerate-format Word outputs. It also powers full Pharmacokinetics and Pharmacodynamics workflows, covering every phase of a study and handling the most data-dense sections with the depth and precision of a senior medical writer. Lay Summaries are equally live — delivered through an in-house regulatory-compliant GenAI agent with ICHE3, EU, and UK guardrails, not free-text generative AI.In active rollout are Module 2.7.4 Summary of Clinical Safety and the Investigator’s Brochure, both landing in Spring/Summer 2026. Beyond that, TriloDocs is undergoing a controlled expansion toward patient summaries, Module 2 CTD summaries, and select Module 1 components under sponsor guidance.TriloDocs is not simply a CSR accelerator. It is a symbolic AI engine for structured, compliant multi-document generation — built for auditability, built for trust, and built to bring new therapies to patients sooner.

Solent University

Business studies, Business studies